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Abstract.  The cutaneous T cell lymphomas (CTCL), 
typified by mycosis fungoides, and several chronic T 
cell mediated dermatoses are characterized by the mi- 
gration of T lymphocytes into the epidermis (epider- 
motropism). Alternatively, other types of cutaneous in- 
flammation (malignant cutaneous B cell lymphoma, 
CBCL, or lymphocytoma cutis, non-malignant T or B 
cell type) do not show evidence of epidermotropism. 
This suggests that certain T lymphocyte subpopula- 
tions are able to interact with and penetrate the epi- 
dermal basement membrane. We show here that T 
lymphocytes derived from patients with CTCL (HUT 
78 or HUT 102 cells), adhere to the detergent-insolu- 
ble extraceilular matrix prepared from cultured basal 
keratinocytes (HFK ECM). HUT cell adhesion to 
HFK ECM was inhibitable with monoclonal antibodies 
(mAbs) directed to the or3 (P1B5) or/31  (P4C10)  inte- 
grin receptors, and could be up-regulated by an acti- 
vating anti-/31 mAb (P4G11).  An inhibitory mAb, 
P3H9-2,  raised against keratinocytes identified epili- 
grin as the ligand for tx3/31 positive T cells in HFK 
ECM.  Interestingly, two lymphocyte populations could 
be clearly distinguished relative to expression of c~3/31 
by flow cytometry analysis. Lymphokine activated killer 
cells, alloreactive cytotoxic T cells and T cells derived 
from patients with CTCL expressed high levels of 
ix3/31 (ot3/31r~gh). Non-adherent peripheral blood mono- 
nuclear cells, acute T or B lymphocytic leukemias, or 
non-cutaneous T or B lymphocyte cell lines expressed 
low levels of ot3/31 (ot3/3pw). Resting PBL or ct3/31  l°w 
T or B cell lines did not adhere to HFK ECM or 
purified epiligrin. However, adhesion to epiligrin could 
be up-regulated by mAbs which activate the/31  sub- 
unit indicating that ix3/31 activity is a function of ex- 
pression and affinity.  In skin derived from patients 
with graft-vs.-host (GVH) disease, experimentally in- 
duced delayed hypersensitivity reactions, and CTCL, 
the infiltrating T cells could be stained with mAbs to 
c~3 or/31 and were localized in close proximity to the 
epiligrin-containing basement membrane. Infiltrating 
lymphocytes in malignant cutaneous B disease (CBCL) 
did not express ct3/31 by immunohistochemical tech- 
niques and did not associate with the epidermal base- 
ment membrane. The present findings clearly define a 
function for c~3/31 in T cells and strongly suggest that 
ot3/31 interaction with epiligrin may be involved in the 
pathogenesis of cutaneous inflammation. 
YMPHOCYTE-mediated cutaneous  dermatoses  can  be 
broadly categorized (Kurtin et al., 1986; Knobler and 
Edelson, 1986) into those which involve the super- 
ficial dermis and epidermis (T cell type) or those that involve 
the deep or reticular dermis (B cell type). The so-called T 
cell pattern is histologically characterized by a lichenoid in- 
filtrate whereby the T cells are concentrated in a bandiike 
pattern in the papillary dermis and epidermis often obscur- 
ing the basement membrane zone (Knobler and Edelson, 
1986; Kurtin et al., 1986; Murphy and Mihm, 1986). Lichen 
planus, graft vs.-host disease and the group of cutaneous T 
cell lymphomas (CTCL) 1  typified by mycosis fungoides are 
examples of cutaneous T cell disorders which have a classic 
1. Abbreviations  used in this paper: AAT, adenine/aminopterin/thymidine; 
ALL,  acute  lymphocytic  leukemias;  BMZ,  basement  membrane  zone; 
CBCL, cutaneous B cell lymphoma; CTCL, cutaneous T cell lymphoma; 
T cell pattern of infiltration. In addition, in CTCL significant 
epidermotropism (migration into the epidermis) occurs and 
Pautrier microabscesses containing T cells are often  observed 
in the epidermis (Knobler and Edelson, 1986). Migration of 
T  cells  into the epidermis is  also  characteristic of other 
dematoses such as contact dermatitis. In contrast, cutaneous 
B cell lymphomas (CBCL) and the group of non-malignant 
disorders referred to as pseudolymphoma or lymphocytoma 
cutis are not characterized by the migration of cells into the 
epidermis (Kurtin et al., 1986). Rather, these disorders show 
CTL, cytotoxic T lymphocyte;  ECM, extracellular  matrix;  EPI, epider- 
mis; HFF, human foreskin fibroblast; HFK, human foreskin keratinoeyte; 
ICAM,  intercellular  adhesion  molecule;  KGM, keratinocyte  growth me- 
dium;  LECCAM, lectin-like  cell adhesion  molecule;  MF, mycosis fun- 
goides; PBL, peripheral blood lymphocyte; VCAM, vascular cell adhesion 
molecule. 
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ticular dermis often with relative  sparing  of the papillary 
dermis or the subepidermal collagenous  (grenz) zone (B cell 
type).  The  mechanisms  operating  to determine the spec- 
ificity  of T or B cell localization  in the skin are presently 
unknown. 
Integrins  are a family of heterodimers that are involved in 
a variety of cell-cell and cell-matrix interactions  (Hynes, 
1992). In hematopoietic cells the/~1 (VLAs) and/$2 (LFA, 
Mac-l, p150/95) integrins are widely expressed and mediate 
the adhesion of such cells to extracellular  matrix  proteins 
(ECM) (collagens,  fibronectins,  laminins)  and the vascular 
cell adhesion  molecules (ICAMs 1-3, VCAM) (reviewed by 
Hemler, 1990; Osborn,  1991; Lasky,  1992; Hynes, 1992). 
In the skin,  integrins,  and their ligands/co-receptors  have 
been implicated  in keratinocyte  desmosome and hemides- 
mosome function (Carter et al.,  1990a, b; Larjava  et al., 
1990; Symington et al., 1993), vascular emigration of neu- 
trophils  (/T2/ICAM) and  T  lymphocytes  (c~4/ffl/VCAM) 
(Wysocki and Issekutz, 1991; reviewed by Lasky, 1992), and 
the/~2/ICAM pathway has been implicated  in the retention 
of T lymphocytes in inflammatory epidermis (reviewed by 
Walsh  et al.,  1990;  Barker,  1991; Barker and  Nickoloff, 
1992). However, the migration  of T cells into the epidermis 
necessarily requires such cells to penetrate the epidermal 
basement membrane. ICAM or VCAM interactions  cannot 
account for this  since these integrin  co-receptors are not 
known to be constituents  of the epidermal basement mem- 
brane. Recently, the ot3#l integrin  has been reported to be 
the receptor used by keratinocytes to adhere to epiligrin,  a 
newly described component of epithelial  basement mem- 
branes (Carter et al.,  1991). However,  the mechanisms  T 
cells  used  to  adhere  to  and  subsequently  penetrate  the 
epidermal basement membrane are completely unknown. 
The  epidermal  basement  membrane  is  synthesized  by 
basal keratinocytes and many of its components can be de- 
tected in the detergent  insoluble matrix deposited by such 
cells in culture. Therefore, in the present paper, we examined 
the ability of various T (or B) cell populations to adhere to 
the ECM synthesized by cultured human  foreskin keratino- 
cytes (HFK). The results of these studies  show clearly that 
cultured cells from patients  with CTCL exhibited  a  clear 
preference for matrix derived from keratinocytes.  Inhibition 
studies with mAbs directed to integrin  receptors and ker- 
atinocyte matrix molecules revealed that CTCL adhesion  to 
HFK ECM was a function  of a3~l  interaction  with epili- 
grin.  Immunoperoxidase staining  analysis  of cutaneous T 
cell lymphoma and other inflammatory  dermatoses revealed 
that the infiltrating T calls expressed ot3/ffl and could be de- 
tected in the basement membrane zone in close association 
with epiligrin.  In contrast,  infiltrating cells in CBCL did not 
stain with mAbs to c~3 and did not associate with the base- 
ment membrane or epidermis.  The present findings clearly 
define a function for ot3/31 in T cells and suggest a mecha- 
nism for T lymphocyte migration into the epidermis that may 
involve ot3B1 interaction  with adhesion  molecules such as 
epiligrin  in the epidermal basement membrane. 
Methods and Materials 
Materials 
Protein-A and -G agarose, PMSF, N-ethylmaleimide (NEM) and BSA were 
from Sigma Immunochemicals (St. Louis,  MO). Peroxidase-  and fluores- 
cein-conjugated  (goat) anti-mouse IgG (H and L chains) or peroxidase- and 
rhodamine-conjugated (goat) anti-rabbit lgG and IgM (H and L) were ob- 
tained from Vector Laboratories (Vecta-Stain Elite Kit; Burlingame,  CA) 
and Tago, Inc.  (Burlingame,  CA).  [StCr]sedium  chromate was from New 
England Nuclear (Boston, MA) and 135S]methionine and cysteine  were 
from Amersham Corp.  (Arlington Heights,  IL). Phyccerythrin-conjugated 
avidin was from Cal-Tag (San Francisco, CA). N-hydroxysucciuimide-biotin 
was from Pierce (Rockford,  IL). 
Cells and Cell Culture 
Normal newborn HFKs were prepared as described (Carter et al., 1991) and 
were maintained in serum-free keratinocyte  growth medium (KGM;  Clo- 
netics, San Diego, CA). KGM contained insulin, EGF, hydrocortisone,  and 
bovine pituitary extract.  Primary cultures of human foreskin fibroblasts 
(HFFs) were prepared by collagenase digestion of neonatal foreskins as de- 
scribed (Carter et al., 1991). Plastic non-adherent  peripheral blood lympho- 
cytes were obtained from normal donors and were prepared as described 
(Wayner et al.,  1988, 1989). Acute lymphocytic  ieukemias (ALL), T or B, 
were obtained from the peripheral blood of individuals undergoing  treat- 
ment at the Fred Hutchinson Cancer Center (Seattle,  WA) and were the 
generous gift of Dr.  Bob Andrews (Seattle,  WA). The ALL were frozen 
(FBS 90% and DMSO  10%) and stored in liquid nitrogen before use. 
The monoclonal C1C4 HLA BT-specific cytotoxic T lymphocyte (CTL) 
cell line has been described (Wayner et al.,  1988, 1987). C1C4 cells were 
maintained in 10 U/ml recombinant IL-2 (Dr. D. Urdal, Immunex, Seattle, 
WA) and were routinely used 7-10 d after antigen stimulation with an HLA 
B7-positive  EBV-transformed  B  cell  line  (ST-l).  Lymphokine-activated 
killer cells or LAK cells were generated by incubating freshly derived 
PBMC in RPMI-1640 supplemented with 10% FBS and 500 U/ml IL-2 for 
7-10 d (Wayner et al., 1988). Molt 4 (human non-cutaneous CIM+ T cell 
leukemia), HUT 78 (human CIM+ T cell lymphoma isolated from a patient 
with Sezary's syndrome),  HUT 102 (human cutaneous CIM+ T cell lym- 
phoma isolated from a patient with mycosis fungoides), WI-38 (diploid lung 
fibroblasts),  Ramos (human Burkitt lymphoma), U937 (human monocytic 
leukemia), HTI080 (human fibrosarcoma),  PC3 (pancreatic carcinoma), 
and A431 (epidermoid carcinoma) cells were obtained from the ATCC. The 
human KCA (B lymphoblastoid) cell line was a generous gift from Dr. Eu- 
gene Butcher (Stanford University, Stanford, CA), the K562 (erythroleuke- 
mia) cell line was a generous gift from Dr. Yoshi Takada (Scripps Clinic, 
La Jolla, CA), the UCLA P3 (carcinoma) cell line was a generous gift from 
Dr.  David  Cheresh  (Scripps  Clinic),  and  the  A375  (melanoma,  low 
metastatic variant) and H2981 (lung carcinoma) cells were a generous gift 
from Dr. Diane Horn (Oncogen,  Bristol-Myers Squibb, Seattle, WA). The 
Jurkat cell line (human non-cutaneous CIM+ T cell leukemia)  was as de- 
scribed (Wayner et al.,  1988, 1989). Unless stated otherwise, all cell lines 
were maintained in RPMI-1640  supplemented with 10% FBS (Hyclone). 
Preparation of  ECM Adhesive Ligands 
Pepsinized human laminin from placenta was a  generous gift from Dr. 
Helena Hessle (Telios Corp., La Jolla, CA). Human plasma fibronectin  and 
collagens  types I and III were prepared as described (Wayner and Carter, 
1987; Wayner et al.,  1988).  Epiligrin was immunoaltinity purified  from 
HFK culture supernatant as described (Carter et al.,  1991). 
Preparation of  EC  M 
ECM from human foreskin keratinocytes  or carcinoma cell lines was pre- 
pared by growing cells for 3-4 d in KGM (HFK) or RPMI 10% FBS (carci- 
nomas) on 48-well tissue culture plates (Costar Corp., Cambridge, MA) as 
described (Carter et al.,  1991). The cell layer was removed by sequential 
extraction with I% vol/vol Triton X-100 detergent in PBS, 2 M urea in 1 M 
NaCI,  and 8 M urea.  All extraction buffers contained 1 mM PMSF and 2 
mM NEM as protease inhibitors. The ECM was further digested with 10 
#g/ml DNAase for 30 min in 1% heat-denatured BSA before use in cell 
adhesion assays. ECM derived from WI-38 fibroblasts was prepared exactly 
as described (Wayner et al.,  1988). 
mAbs 
mAbs to Basement Membrane Components. Monoclonal anti-laminin  was 
a  generous gift from Dr.  Eva Engvall  (La Jolla Cancer,  La Jolla, CA), 
monoclonal anti-entactin (A9) was a generous gift from Dr.  Alfred Fish 
(Department  of Pediatric  Nephrology,  University of Minnesota,  Min- 
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Dako Corp.  (Carpinteria, CA). mAbs to epiligrin (P1E1, P3H9-2, P3E4) 
and fibronectin (PIHll, P3D4) were produced by the methods of Oi and 
Herzenberg (1980) and Taggart and Samloff (1983) as described (Wayner 
and Carter,  1987; Wayner et al.,  1988, 1989;  Garcia-Pardo et al.,  1992) 
using cultured keratinocytes or purified plasma fibronectin  as immunogens. 
Spleen cells from immune RBF/Dn mice were fused with NS-1/FOX-NY 
myeloma cells. Viable heterokaryons  which secreted antibodies specific for 
epiligrin or fibronectin were selected in RPMI 1640 medium supplemented 
with adenine/aminopterin/thymidine  (AAT). mAb P1E1 (anti-epiligrin)  has 
been described (Carter et al., 1991) and was used to immuno-affinity purify 
epiligrin from HFK-conditioned  cultured medium. 
mAbs to Integrin Receptors. mAbs to the integrin receptors ~1 (P4C10), 
a2#l (P1H5), cd~l (PIB5, P1F2), a4~l (P4C2, P4G9),  ~5B1 (P1D6), and 
ave5 have been described (Wayner and Carter,  1987; Wayner et al.,  1988, 
1989,  1991; Carter et al.,  1990a).  mAb P4H9 is an anti-if2  (CD18) mAb 
that was raised against normal PBL. In immune precipitation experiments 
it preclears a prototype anti-~2 reagent, 60.3 (Beatty et al.,  1983). P4H9 
completely  inhibits  several  ~2-dependent  functions:  CTL-  and  NK- 
mediated cytotoxicity,  MLR reactivity and homotypic B cell aggregation. 
The activating anti-B1 mAb P4G11 was raised against U937 cells and was 
selected for its ability to up-regulate hematopoietic cell adhesion to surfaces 
coated with plasma fibronectin.  Monoclonal anti-avB3 was a generous gift 
from Dr. David Cheresh (Scripps Clinic) and anti-c~l (TS2/7) was a gener- 
ous gift from Dr.  Martin Hemler (Dana Farber). 
mAbs were purified from culture supernatant or ascites fluid (athymic 
mice) on a protein G sepharose column (Sigma Immunochemicals). FITC- 
conjugated T cell (CD3,  CD4, CD7, CDS, CD45RO)  and B cell (CDI9) 
specific  antibody reagents  were purchased from Dako  Corp.  The anti- 
CD45RO reagent,  UCHL-1,  has been used to define a subpopulation of 
"memory" T cells (Akbar et al.,  1988; Merkenschlager et al.,  1988). 
Adhesion Assays 
The cell substrate adhesion assay using ECM (HFK or WI-38) or purified 
ECM ligands  and 51Cr-labeled cells was exactly as previously described 
(Wayner and Carter,  1987; Wayner et al.,  1989; Carter et al.,  1991). Non- 
adherent cells were removed by washing with PBS supplemented with 1 mM 
CaCI2 and the adherent cells were dissolved in SDS/NaOH and quantitated 
in a gamma counter. 
Modulation  of ceU-substrate  adhesion  with  mAbs.  The  effects  of 
modulating antibodies to integrin receptors on T cell adhesion were deter- 
mined as previously described (Wayner et al.,  1989; Wayner and Kovach, 
1992).  Cells were labeled with Na251CrO4 (50/.tCi/ml for 2-4 h) and al- 
lowed to adhere to protein- or matrix-coated surfaces for 30-60 rain in the 
presence (or absence) of mAbs known to perturb integrin activity. 
Flow Cytometry Analysis 
Expression of or3 and/~1 by cultured hematopoietic cells in suspension was 
evaluated by indirect immunofluorescence  staining and flow cytometry.  The 
data were analyzed using CONSORT  30 software on a FACScan (Becton 
Dickinson, Mountain View, CA). Positive fluorescence  was determined on 
a four decade log scale and fluorescence  intensity (log F0 was expressed 
as the mean channel number of 5,000 cells.  In tabulated data, the back- 
ground fluorescence was subtracted. Analysis of or3 expression on freshly 
derived peripheral blood lymphocyte subpopulations or frozen acute lym- 
phocytic  leukemias  (T  or  13)  was  accomplished  by  dual-label  im- 
munofluorescence staining and flow cytometry.  For dual-label studies pe- 
ripheral blood T lymphocytes,  "memory" T lymphocytes or B lymphocytes 
were identified  with FITC-conjugated  mAbs to CD3,  CD45RO or CD19 
(Dako Corp.,  respectively),  o~3 was detected with biotinylated PIF2 and 
phycoerythrin-conjugated avidin (Cal-Tag Labs, San Francisco,  CA). 
Biopsy Specimens and Immunohistochemical Staining 
Biopsy  specimens (4-mm punch) from patients with established contact 
hypersensitivity reactions (n  =  5) (Waldorf et al.,  1991), epidermotropic 
cutaneous T cell lymphoma (patch and plague-stage  MF; n=10), chronic 
cutaneous GVH disease (n  ---2), and cutaneous B cell lymphoma (n=5) were 
snap frozen in liquid nitrogen or first embedded in OCT, and then snap fro- 
zen in isopentane. Sections were prepared with a cryostat at 5- or 6-tzm in- 
tervals.  Normal scalp skin was a generous gift from Dr. Maria Hordinsky 
(Department of Dermatology,  University of Minnesota). The GVH tissues 
were derived from patients with acute disease and were the generous gifts 
of Dr.  George Sale  (Fred Hutchinson Cancer Center).  The infiltrating 
mononuclear cells were determined to be "activated or memory" T lympho- 
cytes by standard immunohistoehemical techniques (CD3  +, CD4  +, CD8  +, 
CIM5RO  +, CD45RA-). In other studies,  serial sections were stained by 
immunohistochemistry with the following  mAbs:  Leu  1 (CD5),  Leu 2 
(CDS),  Leu 3 (CIM), Leu 4 (CD3), Leu 5 (CD2), Leu 6 (CD1), Leu 12 
(CD19), and anti-r and anti-h immunoglobulin  light chains (Becton Dickin- 
son). All cases were also stained for a2 (P1H6), ~3 (P1F2), and B1 (P4C10). 
Selected cases (at least two from each category)  were also stained for a4 
(P4G9) and a5 (P1D6). Isotype-matched  irrelevant mAbs served as negative 
controls. Dual-label immunofluorescence  staining of snap frozen tissue was 
performed with:  (a)  UCHL-1  anti-CD45RO or anti-CD3 detected with 
rhodamine conjugated  goat anti-mouse; and (b) biotinylated P1E1 anti- 
epiligrin detected with FITC-conjugated  avidin.  In three cases of MF and 
two cases of contact dermatitis,  conventional transmission  EM was also per- 
formed to assess spatial relationships between infiltrating lymphocytes  and 
the basement membrane zone. 
Immune Precipitation, Sequential Immune 
Precipitation, and SDS-PAGE 
Viable cells were surface labeled with t25I or NHS-biotin or metabolically 
labeled  with  [3SS]methionine and cystine  0Vayner  and  Carter,  1987; 
Wayner et al., 1991) followed by extraction with 1% Triton X-100 detergent 
in PBS supplemented with 1 mM CaCI2.  1 mM PMSF and 1 mM NEM 
were used as protease inhibitors. Immune precipitations,  sequential  im- 
mune precipitations,  and SDS-PAGE were carried out exactly as previously 
described (Wayner and Carter, 1987; Wayner et al., 1989). The identity of 
the proteins immune precipitated from detergent extracts  of cells by the 
putative upregulating  anti-~l mAb, P4G11, was determined by sequential 
immune precipitation or pre-clearing analysis with a known anti-~l mAb, 
P4C10 (Carter et al.,  1990a,b). 
Results 
Adhesion of T Cells to HFK Matrix 
The epidermal basement membrane is thought to be synthe- 
sized by basal keratinocytes and many of its components can 
be detected in the detergent insoluble ECM deposited by 
such cells in culture. Therefore, we examined the ability of 
the ECM deposited by cultured human foreskin keratino- 
cytes (HFK) to support the adhesion of various T and B cell 
populations. 
T cells differed dramatically in their ability to adhere to 
HFK ECM (Table I). Of the tumor cell lines we examined, 
only T lymphocytes established from patients with CTCL 
(HUT 102 or HUT 78) could adhere to HFK matrix (Table 
I).  T  cells  established  from patients  with non-cutaneous 
leukemia (Molt 4) or lymphoma (Jurkat) did not attach to 
HFK matrix. With regard to non-malignant T cell popula- 
tions,  unactivated, plastic  non-adherent peripheral  blood 
mononuclear cells (85%  T  cells) did not adhere to HFK 
ECM while cultured alloantigen specific cytotoxic T cells 
(CTL) and IL-2-activated LAK cells exhibited significant 
binding. As we have previously reported, HT1080 cells ad- 
here to HFK matrix and are included as a positive control. 
Interestingly, none of the B cell lines we examined adhered 
to HFK matrix. All of the T and B cell populations attached 
to  matrix  derived  from  WI-38  fibroblasts  (not  shown) 
demonstrating that the failure of non-cutaneous T cells and 
B cells to bind HFK ECM was not due to an inability to bind 
secreted  matrix.  WI-38  matrix,  as  we  have  previously 
reported,  contains  multiple  adhesive  ligands  including 
fibronectin and collagen (Wayner et al.,  1988). 
Lymphocyte Adhesion to HFK ECM Is Correlated 
with Expression of  u3B1 
As we have already reported, keratinocytes and other non- 
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T cells  ADHESION (HFK ECM)*  c~3 (MFI)*  /31 (MFI) 
HUT 78 (Sezary's)  89  48  61 
HUT  102 (Mycosis fungoides)  76  79  156 
CTL (cytotoxic T lymphocyte)  42  32  141 
LAK (IL-2 activated killer cell)  22  46  189 
HSB-2 (non-cutaneous  leukemia)  12  13(Sh)§  118 
Jurkat (non-cutaneous  lymphoma)  2  10(Sh)  174 
Molt 4 (non-cutaneous  leukemia)  4  9(Sh)  118 
ALL-T (3)  ND  -  98 
B cells 
ST-1 (EBV transformed cell line)  0  8(Sh)  28 
Ramos (Burkitt's lymphoma)  2  -  76 
KCA (B lymphoblastoid)  8  l l(Sh)  51 
ALL-B (3)  ND  -  46 
Other 
PBMC (T and B)  0  6.0(Sh)  6611 
K562 (erythroleukemia)  0  -  19 
HTI080 (fibrosarcoma)  108  446  584 
PC3  (carcinoma)  92  184  278 
A375  (melanoma)  86  23  62 
* Adhesion expressed  as percent of Con A (5 tLg/ml)  control. 
MFI, mean fluorescence  intensity  calculated  as mean channel number minus the mean channel number for the negative  non-immune lgG control. 
§ Sh indicates a shift in the positive direction  of the entire population  and a (-) indicates  no detectable  fluorescence. 
II Two subpopulations  (~1  ~¢' and ~lt°~).  The value shown in the table is the MFI calculated  for the whole population. 
Adhesion  ofT or B cell populations  to ECM derived  from HFK: correlation  with c~3 expression.  For matrix  production,  the HFK were grown on 48-well  tissue 
culture  plates. HFK matrix  and the adhesion  assay  were exactly  as previously  described  (Carter  et al,, 1991), Surface  expression  of et3 was detected  by flow cyto- 
metric analysis  of ceils stained  with an a3-specifie  m.Ab (P1B5) exactly  as described  (Wayner  et al., 1988; Wayner  et al,, 1989). Histograms  were generated on 
a four log scale, analyzed  with Consort 30 software  and are expressed  as MFI. Fc receptors  were blocked  with purified  goat IgG (50 ~g/ml). Staining  for flow 
cytometry analysis  was carried out at 4°C in the presence of 0.02% sodium  azide and 1% normal goat serum. 
epithelial cell populations use the integrin ot3/31 to bind to 
their secreted matrix (Carter et al., 1991).  ot3fll expression 
on lymphocytes, however, is highly restricted (Wayner et al., 
1988; Hemler,  1990).  Therefore, we performed the follow- 
ing experiments to see if T  cell adhesion to HFK ECM was 
correlated with expression of ot3/31. 
The cells in Table I could be clearly divided into two popu- 
lations relative to ot3/31 expression (ot3~ag  h and ot31°w), Only 
those cells able to adhere to HFK matrix expressed high lev- 
els of c~3131: CTCL (HUT 78 or HUT 102), LAK, and CTL 
were Ot3/31hig  h while non-cutaneous T  cells (Molt 4  and Jur- 
kat), freshly derived PBMC, and all of the B cell populations 
we examined were ot3131  z°W. The cultured T  or B  cell lines 
could not be so easily distinguished based on surface expres- 
sion of other integrins such as ot4~l or c~5fll (not shown). 
All plastic non-adherent PBMC were weakly positive for or3 
(Table I) and in some individuals, there appeared to be a sub- 
population of cells which stained more brightly with rnAbs 
to or3. Interestingly, in such individuals, this sub-population 
also  stained  with  UCHL-1  (anti-CD45RO)  identifying  it 
as  a  "memory"  T  cell  subset  (Akbar  et  al.,  1988).  The 
c~3fll  hiSh phenotype was also correlated with the expression 
of the CD45RO epitope in cultured T cell populations (HUT 
78, CTL, LAK, but not Jurkat or Molt 4). As we and others 
have reported, HT1080 fibrosarcoma cells, A375 melanoma, 
and several carcinoma cell lines (A431 and PC3 cells) also 
expressed high levels of ot 3131. Immunoprecipitation analy- 
sis with anti-or3 revealed that in CTL and HUT 78 cells, the 
integrin c~3 chain was  found in the form of a  heterodimer 
containing a/31-like subunit (Fig. 1). The presence of 131 was 
confirmed by preclearing T  cell detergent extracts with an 
anti-131  rnAb  (P4C10)  before  immune  precipitating  with 
anti-or3  (P1B5).  Under  these  conditions  no  or3  could  be 
precipitated (not shown). Jurkat cells, which are o~3¢~1  ~°w by 
flow cytometry, and HT1080 cells, which as we have already 
reported,  are  ot3/31~g  h (Wayner and  Carter,  1987)  are  in- 
cluded as controls. The conjugates of cd,  or2,  or4 (p80/70, 
cleaved form), or5, and o~6 complexed with 131 could also be 
immune precipitated from CTL, and cd, or4 (predominantly 
Figure I. Immunoprecipitation of c~3131 from CTL, HT1080,  HUT 
78, or Jurkat cells. Surface labeled  ceils were extracted with 1% Tri- 
ton X-100 in PBS, pH 7.4, containing 1 mM CaC12 and protease 
inhibitors as previously described (Wayner and Carter, 1987; Way- 
ner et al., 1989).  Precipitation of integrins from detergent extracts 
of cells with mAbs bound to protein A-sepharose was carried out 
exactly as previously  described (Wayner and Carter, 1987) and sub- 
jetted to autoradiography. The antibodies used were: Control, SP2 
myeloma culture supernatant (lane 1); anti-e~3, P1B5 (lane 2); anti- 
/31, P4C10  (lane 3). 
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Figure 2. Hut 78 cell adhesion to ECM derived from HFK or WI-38 
fibmblasts: effect of anti-integrin mAbs. Cell adhesion to matrix in 
the presence of anti-integrin mAbs was exactly as described for 
Table I. mAbs used were: P4C10, E1 (inhibitory), TS2/Z al (non- 
functional), PIH5, t~2 (inhibitory), PIBS, c~3 (inhibitory); P4C2, ct4 
(inhibitory), PID6, ~5 (inhibitory); GoH3, ~6 (inhibitory); P4Hg, 
f12 (inhibitory). 
p150, uncleaved form) and ot5 complexed with/31 could be 
precipitated from HUT 78 cells (not shown). 
T Cells Use ~3B1 to Bind HFK and Carcinoma 
Cell Matrix 
To directly test the possibility that T cells use ot3/31 as the 
receptor for HFK matrix, we examined the attachment of 
HUT 78 cells to HFK ECM in the presence of mAbs to in- 
hibitory epitopes on various integrin receptors (Fig. 2). The 
data summarized in Fig. 2 show that HUT 78 cell adhesion 
to HFK matrix (solid bars) can be completely abrogated by 
antibodies to or3 (P1B5) or/31 (P4C10). Inhibitory antibodies 
to or2 (P1H5), c~4 (P4C2),  or5 (P1D6), c~6 (GoH3), otv//33 
(LM609), otv//35 (P3G2), or/32 (P4H9) either alone or in 
combination (for ct4 and c~5) had no effect on HUT 78 cell 
adhesion to HFK matrix clearly indicating that the T lym- 
phocyte receptor for HFK matrix is the functional conjugate 
oft~3 with/31. HUT 78 cells could also adhere to matrix de- 
rived from WI-38 fibroblasts (Fig.  2, striped bars).  How- 
ever, this interaction was mediated primarily by fibronectin 
as mAbs to/31 (P4C10) or the lymphocyte fibronectin recep- 
tors,  ct4/31 or ot5/~l  (P4C2 and P1D6,  respectively) when 
used in combination completely inhibited this process. In- 
terestingly, HUT 78 (Fig. 3) or HUT 102 (not shown) cells 
adhered to the ECM deposited by several malignant epithe- 
lial cell lines (Fig. 3, A431, HT29, UCLA P3). Adhesion of 
HUT cells to the ECM deposited by carcinoma cells could 
also be specifically inhibited by mAbs to a3 (Fig. 3, P1B5) 
or/31 (not shown). These findings strongly suggest that the 
ECM derived from keratinocytes and epithelial tumor cell 
lines  is unique and capable of supporting the adhesion of 
t~3/31-positive T  lymphocytes. 
T Cell Adhesion to HFK ECM via t~3fll Can 
Be Inhibited by Anti-Epiligrin mAbs 
Since epiligrin is the component in HFK matrix responsible 
for o~3/31-dependent keratinocyte adhesion  (Carter  et al., 
1991) it was of interest to determine whether HUT 78 cells 
could attach to surfaces coated with purified epiligrin (Fig. 
4 A). As expected, these cells adhered to epiligrin and rnAbs 
to ct3 or/31  (Fig. 4 B) completely inhibited this. mAbs to 
other integrin receptors (or2, P1H5; a4,  P4C2;  or5, P1D6; 
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Figure 3. Adhesion of HUT 78 ceils to ECM derived from HFK 
or epithelial cell lines. All epithelial cells were grown to confluency 
in 48-well plates. They were extracted as previously described and 
blocked with PBS supplemented with HBSA (Wayner  et al., 1989). 
5~Cr-labeled HUT 78 ceils were allowed to adhere to ECM-coated 
plates in the presence of purified mAb directed to c~3 (PIBS, 10 #g/ 
ml) for 30 min. Bound HUT 78 cells were quantitated as described 
in the Materials and Methods and the legend to Table I. 
c~6, GoH3;/32, P4H9; c~v/33, LM609; t~v/35, P3G2) had no 
effect, c~3BP  °w lymphocyte populations (such as Jurkat or 
ST-1 cells) did not adhere to surfaces coated with purified 
epiligrin (not shown) although such cells could adhere to 
surfaces coated with fibronectin (not shown). 
These data (Fig. 4 A) strongly suggest that T cell adhesion 
to  HFK  ECM  is  a  function  of  ct3/31 interaction  with 
epiligrin. However, in addition to epiligrin, HFK ECM con- 
tains  adhesion molecules such as fibronectin and laminin 
(Fig. 5 A, P1Hll and 4C7) that have also been reported to 
be ligands  for ol3/31 (Gehlsen et al.,  1990;  Elices et al., 
1990).  Therefore, to determine the factor responsible for 
HUT 78 cell adhesion in HFK ECM we developed mAbs to 
HFK cells and screened them for: (a) their specific reactivity 
with HFK ECM; and (b) their specific ability to inhibit HUT 
78 cell adhesion to secreted matrix. Of these, P3H9-2 and 
P3E4 reacted strongly with HFK ECM (Fig. 5 A) but not 
with  WI-38  ECM,  purified  human  fibronectin,  human 
placental laminin or collagen types I  or m  (not shown). 
P3H9-2 completely inhibited HUT 78 cell adhesion to intact 
HFK ECM (Fig. 5 B) or purified epiligrin (not shown) but 
had  no effect on adhesion of these cells to WI-38  ECM 
or purified fibronectin (not shown).  P3H9-2 also inhibited 
HUT 78 cell adhesion to ECM prepared from A431 cells 
(not shown) strongly suggesting that T cell adhesion to carci- 
noma ECM is also epiligrin dependent. Immune precipita- 
tion  analysis  with  [35S]methionine-labeled  HFK-condi- 
tioned  culture  medium  revealed  that  P3H9-2  immune 
precipitated an epiligrin complex identical to that precipi- 
tated by our previously described anti-epiligrin, mAb P1E1 
(Fig.  6).  In  sequential  immune  precipitation experiments 
P3H9-2 precleared the epiligrin complex recognized by P1E1 
from HFK conditioned culture medium (not shown). In tis- 
sue, P3H9-2 and P1E1 had a similar, if not identical, staining 
pattern (Fig. 7, A and C). Interestingly, we observed exten- 
sive epithelial and endothelial basement membrane staining 
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Figure 4. Adhesion of  HUT 78 
ceils to purified epiligrin and 
role  of a3/31.  (A)  Adhesion 
of HUT 78 cells to purified 
epiligrin or other ECM adhe- 
sive  ligands. HBSA, heat- 
denatured BSA (Wayner  et al., 
1989);  EPI, P1E1 affinity- 
purified epfligrin; type L hu- 
man pepsinized type ! colla- 
gen  from placenta;  type Ill, 
human  pepsinized  type  III 
collagen from placenta; lami- 
nin, human-pepsinized lami- 
nin from placenta;  pFN, human 
plasma fibronectin. All adhe- 
sive ligands were used at 5 #g/ 
ml coating concentration. (B) 
Inhibition of HUT 78 cell ad- 
hesionto P1E1  affinity-purified 
epiligrin (Caneret al., 1991) with anti-integrin mAbs. Adhesion to purified epiligrin (5/~g/ml coating concentration) was carded out in 
the presence of the indicated mAbs (ascites at 1/100). 
with P3H9 in normal skin (Fig. 7, A and C, scalp) and tonsil 
(not shown). 
T Cell Adhesion to HFK ECM and Epiligrin Can 
Be Up-regulated by mAbs to [31 
Several T lymphocyte/31 integrins (a4/31, c~5/31, c~6/~1) have 
been shown to require activation for ligand binding to occur 
(reviewed by Shimizu and Shaw,  1991).  Activation can be 
achieved with T cell receptor cross-linking, phorbol esters, 
and mAbs to the integrin/31 subunit. However, it is not yet 
known whether ot3/31 is similar and can also be activated for 
ligand binding. Therefore, we examined the effects of several 
activating mAbs to/31 (P4G11) for their ability to up-regulate 
adhesion of HUT 78 (ot3/31  ~gh) or Jurkat (ot3/31  m°*) cells to 
epiligrin coated surfaces. Activating mAbs (data shown for 
P4G11) were selected for their ability to up-regulate adhesion 
of hematopoietic cells to fibronectin-coated surfaces. In se- 
quential immunoprecipitation experiments they preclear the 
/31 complex from detergent extracts prepared with surface la- 
beled HUT 78 cells (Fig.  8). 
Although  resting  HUT  78  cells express basal  epiligrin 
adhesion, such adhesion could be clearly up-regulated by ac- 
tivation with P4G11 (Fig. 9). Pretreatment with an inhibitory 
anti-/31 (P4C10), however, had the opposite effect. Interest- 
ingly, adhesion of P4Gll-pretreated HUT 78 cells to epili- 
grin could be inhibited by mAbs to or3 (P1B5, not shown) 
showing clearly that up-regulated binding was mediated by 
the functional complex of oe3/31. Interestingly, adhesion of 
Jurkat  cells  to  purified  epiligrin  could  be  slightly  up- 
regulated by P4Gll consistent with the low levels of ot3/31 
expressed by these cells (Table I).  These findings (Fig. 9) 
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Figure 5.  Characterization of 
inhibitory anti-epiligrin mAb, 
P3H9-2.  (A) Composition of 
HFK matrix by ELISA and re- 
activity  with  mAbs  P3H9-2 
and mAbs to epiligrin (PIE1), 
fibronectin  (PIHll),  laminin 
(4C7), entactin (A9), and type 
IV  collagen  (Dako).  HFKs 
were grown to conttuency in 
96-well plates and extracted as 
described (Carter et al., 1991). 
The matrix was stained with 
the indicated mouse mAbs and 
detected with HRP-conjugated 
rabbit anti-mouse  secondary 
antibody (1/1,000) and 
substrate (Kirkgaard and Per- 
ry). (B) Inhibition of HUT 78 
cell adhesion to HFK matrix 
with mAb P3H9-2. All mAbs 
were purified from culture supernatant and were used at 10 #g/ml (control, 10 #g/ml purified mouse IgG). HFK matrix was prepared 
as described in the Methods and Materials. P3H9-2 reacts with P1E1 purified epiligrin by ELISA. PIHll and P3D4 are mAbs directed 
to the central cell binding domain and the carboxy-terminal cell binding domain of fibronectin, respectively. P3D4 inhibits lymphocyte 
adhesion to fibronectin (Garcia-Pardo et al.,  1992). 
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tation  of P1E1- or  P3H9-2- 
reactive  material  from  the 
conditioned  culture  medium 
of  [35S]methionine and  cys- 
teine-labeled HFKs. Immune 
precipitations  were  analyzed 
on a 7 % SDS-polyacrylamide 
gel  under  reducing  condi- 
tions. SP2, Myeloma culture 
supernatant.  The  uppermost 
bands not indicated by molec- 
ular weight represent the lam- 
inin-like complex that co-pre- 
cipitates with epiligrin (Carter 
et  al.,  1991). Three  bands 
composing the epiligrin com- 
plex are indicated (M, =  170, 
140, or 1009. 
show clearly that adhesion of T cells to epiligrin requires the 
participation of an active c~3fll complex and that the failure 
of ot3fll  ~°w cell populations to bind HFK ECM is a function 
of both ot3fll surface expression and activation. 
Co-localization of T Cells with 
the Epiligrin-containing Basement Membrane 
Together, the above data suggest that ot3fll interaction with 
epiligrin may be involved in T  cell adhesion to basement 
membranes in situ.  Therefore, we examined biopsy speci- 
mens from several inflammatory or malignant skin condi- 
tions for the presence and localization of ot3fll-positive T 
cells.  Graft-vs.-host disease is often associated with T  cell 
infiltration of the basal epidermis. In several cases of cutane- 
ous GVH we examined there was a clear tendency for CD3 + 
T cells to be localized in the basement membrane zone (Fig. 
10, C and E) in close association with the epiligrin contain- 
ing  basement  membrane  (Fig.  10,  B  and D).  Dual  label 
studies with mAbs directed to well-characterized T cell anti- 
gens  (CD3,  CD8,  CD45RO)  revealed that  the  infiltrating 
cells in close association with epiligrin (Fig. 11 B) were acti- 
vated or "memory" cytotoxic T  cells (Fig.  11 A, A and B, 
same field). Due to the intense reactivity of basal keratino- 
cytes with mAbs to or3 and the close association of T cells 
with the basal layer (Fig.  11, A and B) it was difficult to de- 
tect T cell specific or3 staining in these specimens even with 
dual label techniques. 
Immunohistochemical Comparison ofT 
or B Lymphocyte Infiltrates in Skin 
We have shown that c~3/31~s  h T cells bind epiligrin in HFK 
matrix, but that non-cutaneous T cells (a3/31 l°w) and B cells 
(a3/31 ~°w) do not bind epiligrin with high affinity even when 
the/31 complex is activated with mAb P4Gll. To better define 
Figure 7. Comparison of immunoperoxidase staining patterns gen- 
erated in normal scalp skin with the mAbs P3H9-2, P1E1, or anti- 
laminin. (A) P1EI reactivity in normal scalp. (B) Negative control 
stained with normal mouse IgG. (C) P3H9-2 reactivity in same tis- 
sue. (D) Laminin detected with 4C7 anti-laminin (Telios). * Indi- 
cates region rich in endothelium, HE hair follicle; arrowheads,  epi- 
dermal basement membrane. 
these apparent associations relative to disease pathogenesis 
and localization of T or B cells within the skin, we examined 
the correlative immunohistochemistry in adjacent tissue sec- 
tions  of benign  T  cell  infiltrates  (contact  dermatitis)  or 
malignant T  cell infiltrates (CTCL) and compared them to 
malignant B cell (CBCL) infiltrates (Fig.  12).  High-resolu- 
tion light microscopy (plastic embedded, 1-#m sections; Fig. 
12, A and B) revealed frequent localization ofT lymphocytes 
in  the basal  layer directly above the  epidermal basement 
membrane in contact dermatitis (Fig. 12 A, arrows). In Fig. 
12 B, the infiltrating cells, in direct contact with the base- 
ment membrane, are stained with a T  cell specific marker, 
Leu I. Transmission EM (Fig. 12 C) confirmed the close as- 
sociation of Leu 1 positive lymphocyte plasma membranes 
(asterisks) with the basement membrane where epiligrin is 
found.  Similar features  were observed in  CTCL biopsies 
(Fig. 12 D) and contrasted sharply with B cell infiltrates that 
did not infiltrate the epidermis or superficial dermal layers 
(Fig. 12 E). In Fig. 12 D, the mycosis fungoides (MF) T cells 
can be seen in association with the BMZ and throughout the 
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Figure 9. Modulation of HUT 78 cell adhesion to epiligrin by mAb 
P4G11. HUT 78 cells (u3fll  ~gh) or Jurkat cells (tx3/3P  °~) were pre- 
incubated with P4G11 (20 t~g/ml), P4C10 (20/xg/ml),  or control 
IgG (20 #g/ml non-immune mouse IgG) at 5  x  105 cells per ml 
for 30 rain at 37°C. At the end of this time they were washed and 
allowed to adhere to epiligrin coated surfaces for 30 rnin at 37°C. 
Figure 8. Identification of activating mAb P4Gll as anti-/31 by se- 
quential immune precipitation analysis with known anti-/~l P4CI0. 
HUT 78 cells were surface labeled and extracted with 1% Triton 
X-100 in PBS as previously described in the legend for Fig. 1. Se- 
quential preclearing was performed with the indicated rnAbs. Four 
rounds of preclearing (Preclear) were carded out for each mAb or 
control supernatant (SP2). After preclearing, the lysates were im- 
mune precipitated (IP) with the indicated mAbs. P4C10 is a previ- 
ously characterized inhibitory anti-/~l (Carter et al.,  1990a,b). 
epidermis (EPI), whereas in Figure 12 E, the BMZ and EP 
are clearly free of B cell infiltrates. In ME the intraepider- 
real  infiltrating cells were identified by immunoreactivity 
with anti-Leu 1 (Fig. 12 F). Expression of a 3 on such cells 
was difficult to differentiate from the intense basal cell reac- 
tivity with PIF2 (anti-ix3)  in all conditions examined. How- 
ever,/31 expression by these cells was more intense and in 
some specimens, T cells in Pautrier microabscesses could be 
clearly distinguished by reactivity with P4C10 (Fig.  12 G). 
This technical problem was not encountered, however, with 
dermal T  cells identified by anti-Leu 1 in MF (Fig.  12 H) 
which in serial sections were shown to demonstrate convinc- 
ing or3 reactivity (Fig.  12 I). The staining observed in Fig. 
12 1 is the result of intense reactivity of dermal T cells with 
FIF2 as the resident dermis (except for the endothelium lin- 
ing the blood vessels) is essentially negative for a3 reactivity 
(see Fig. 12 K). In contrast, dermal B cell infiltrates that ex- 
pressed B cell antigens and monotypic immunoglobulin light 
chains (Fig. 12 J) failed to express o~3 when adjacent serial 
sections were stained under identical conditions (Panel K). 
Compare the intense T cell o~3-immunoreactivity in Fig.  12 
I with the complete lack of dermal B cell o~3-immunoreactiv- 
ity in Fig.  12 K. 
Discussion 
We have recently described a novel cell adhesion molecule 
(epiligrin) synthesized by basal keratinocytes (Carter et al., 
1991). In tissue, epiligrin is localized to the lamina lucida of 
the basement membrane. In culture, epiligrin is a primary 
adhesive ligand synthesized by rapidly growing basal ker- 
atinocytes  and  is  deposited  into  the  detergent-insoluble 
ECM. The receptor for epiligrin used by keratinocytes and 
other non-epithelial cell populations is  the c~3~1 integrin 
(Carter et al., 1991). The results of the present studies show 
unequivocally that T  lymphocytes also use ct3#l to adhere 
to epiligrin in the ECM deposited by normal dermal ker- 
atinocytes or carcinoma cells. 
Although it has been known for some time that ot3/31 is an 
activation-dependent T cell receptor, its function in T cells 
has until now been largely unknown. It is interesting that al- 
though ct3fll has been reported to be a laminin, collagen, 
and a fibronectin receptor in non-lymphoid cell populations 
(Wayner and Carter, 1987; Gehlsen et al., 1989; Dang et al., 
1990; Elices et al.,  1991) HUT 78 cells and CTL appeared 
to  use  ot3/31 exclusively  to  adhere  to  HFK  matrix  or 
epiligrin. In this regard, the Dang et al. (1990) study, in par- 
ticular, deserves comment since these workers reported that 
mAb J143  (anti-or3)  inhibited interstitial  collagen-induced 
CD4+  T  cell activation.  Our  studies  contrast with those 
reported in this previous paper. Although HUT 78 cells ex- 
pressed abundant cell surface o~3 complexed with/31, they 
did not adhere to collagen types I or III. Furthermore, the 
results of inhibition studies with PIB5 (anti-t~3)  and PIH5 
(anti-a2) which are well-characterized inhibitory reagents 
(Wayner and Carter,  1987;  Wayner et al.,  1988; Takada et 
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localization  of  epiligrin  or 
CD3 + T lymphocytes  in cryo- 
stat  sections of skin derived 
from a patient with cutaneous 
graft-vs.-host (GVH) disease. 
(A, B, and C are serial sections. 
The four.large arrows in D and 
E (400x) are included to indi- 
cate reference points for com- 
parison. (A) Phase contrast mi- 
crograph of G'VH skin stained 
with non-immune mouse IgG 
(2  #g/ml).  The  background 
staining with mouse IgG is neg- 
ligible. BM, Epidermal base- 
ment membrane; BMZ, base- 
ment  membrane  zone.  (B) 
Immune  peroxidase  staining 
of epiligrin with  mAb  P1E1 
(Carter et al., 1991). Epiligrin 
staining is coincident with the 
dermal-epidermal  boundary 
or basement membrane (BM, 
arrow).  (  C) Immunolocaliza- 
tion of CD3+  T lymphocytes 
in GVH skin. T  lymphocytes 
are concentrated in the vicin- 
ity of the basement membrane 
in close proximity to the epili- 
grin.  D  and  E  are  higher 
power  views  of  B  and  C 
(400x). Bar (A-C),  100 #m, 
Figure  11.  Co-localization  of 
CD45RO+  T cells and epiligrin in 
human GVH skin. (,4) Immunoflu- 
orescence  staining  with  UCHL1 
anti-CD45RO+, mAb UCHL1 was 
detected with rhodamine conjugated 
goat anti-mouse. (B) Immtmofluo- 
rescence localization of epiligrin. 
Biotinylated  P1E1  (anti-epiligrin) 
was detected with FITC anti-avidin. 
The tissue is the same as that shown 
in Fig. 10. The BMZ is clearly in- 
filtrated  with  large  numbers  of 
CD45RO+  T  cells (CD3+,  Fig. 
10). In Fig. llA, the T cells can be 
seen in intimate contact with the 
epiligrin  containing basement mem- 
brane (,4 and B are the same field, 
arrow marks identical spot in each 
photograph for comparison). 
Wayner et al. ct3~l and T Cell Adhesion to Epiligrin in the Skin  1149 Figure 12. Immunohistochemical localization of T and B lymphocytes in various cutaneous malignant and inflammatory disorders. (A-C) 
Localization of T cells within lower epidermis (EPI,  epidermis; D, dermins) in allergic contact dermatitis. (A) One micron-thick, plastic- 
embedded section, arrowheads, representative lymphocytes above basement membrane (400x); (B) immunoperoxidase stain, Leu 1 (pan 
T cell antigen) (400x); (C) transmission electron micrograph, (*) lymphocytes; (arrowheads) points of close approximation between lym- 
phocyte plasma membranes and basement membrane; (EPI) epidermis; (D) dermis (xS000). (D-K) Comparison of infiltrate patterns 
and antigenic phenotypes between mycosis fungoides (MF) and cutaneous B cell lymphoma (CBCL). (D)MF; (E) CBCL; note prominent 
migration of T cells (Leu 1+) into hyperplastic epidermis (EPI) in D, and sparing of epidermis (EP/) and superficial dermis (D, dermis) 
by B cells (Leu 12+) in E  (D,  Leu 1,  xl00; E, Leu 12,  ×100).  (F) Clusters of Leo l-positive: T cells (arrow) within epidermis (EPI) 
in MF; (G) section adjacent to F stained for/~1 with apparem staining of T cell cluster (arrow) and adjacent basal keratinocytes (arrow- 
heads) (F and G,  x400).  (H) Cluster of Leu 1-positive dermal T cells; (I) section adjacent to H showing cx3 expression by the T cells. 
(J) Cluster of Leu 12-positive dermal B cells inset showing monotypic expression of surface x-type immunoglobulin light chains;  (K) 
section adjacent to J  showing relative absence of ~x3 immunoreactivity on dermal B lymphocytes (H-K,  x800). 
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Carter et al.,  1991) show that in T cells which express both 
t~2Bl  and  ot3/31 collagen  adhesion  is  mediated  by  ot2/31 
(Goldman et al., 1992; Wayner, E. A., manuscript in prepa- 
ration). The results presented here also argue against a role 
for a3/31  as a receptor for fibronectin or laminin. HUT 78 
cells which express ot3/31 do not adhere to mouse laminin 
or human laminin derived from placenta even after activa- 
tion  of  the  /31  complex.  HUT  78  ceils  did  adhere  to 
fibronectin-coated surfaces. However, as we and others have 
reported  (Garcia-Pardo  and  Ferreira,  1990;  Wayner  and 
Kovach, 1992) adhesion of HUT 78 cells to fibronectin in- 
volved the cooperative interaction of ot5/31 and a4~l. mAbs 
to or3  (P1B5)  had  no effect on T  (or B)  cell adhesion to 
fibronectin even if the/31 complex was in an active confor- 
mation. 
The  adhesive  ligand  for  T  cells  in  HFK  ECM  was 
identified as  epiligrin.  This conclusion was  based  on the 
results of several experiments carried out with a monoclonal 
antibody selected for its ability to inhibit T cell adhesion to 
HFK matrix. (a) P3H9-2 reacted only with HFK or carci- 
noma cell matrix and P1E1 purified epiligrin;  (b) P3H9-2 
specifically inhibited HUT 78 cell adhesion to HFK ECM 
or purified epiligrin; (c) P3H9-2 and PIE1 immune precipi- 
tated identical complexes from HFK-conditioned media; and 
(d) the pattern of P3H9-2 immuno-reactivity in tissue was 
similar to that observed for P1E1 and distinct from that ob- 
served for laminin,  type IV collagen,  or fibronectin.  Re- 
cently, ct3/31 has been reported to be a receptor for entactin 
(Dedhar et al.,  1992), an adhesive component of the lamina 
densa (Chung and Durkin,  1990). However, the matrix we 
prepared from HFK and carcinoma cells, that could support 
the efficient adhesion of cr3/31hig  h T  cells, did not contain 
entactin and P3H9-2 did not react with purified entactin. 
Furthermore, HUT 78 cells (a3Bl~g  h) do not adhere to sur- 
faces coated with purified recombinant entactin (Yi, X. Y., 
and E. A. Wayner, manuscript in preparation). Together, the 
present findings  show clearly that in T  cells the primary 
function of c~3B1 is as a receptor for epiligrin. 
Two  T  lymphocyte populations  could be  distinguished 
based on surface t~3/31 expression.  Non-cutaneous T  cell 
lines (Molt 4 or Jurkat), resting peripheral blood mononu- 
clear cells, and all of the cultured B cell populations we ex- 
amined were a3/31 ~°w while antigen or IL-2 activated (CTL, 
LAK),  or  cutaneous  T  cells  (HUT 78,  HUT  102)  were 
o~3/31  hiSh. All of the c~3B1  ~h T  ceils adhered to epiligrin. 
Furthermore, adhesion of HUT 78 cells to epiligrin could be 
upregulated with activating mAbs directed to/31. This sug- 
gests that regulation of ot3/31 function in T cells is similar 
to other B1 integrins. It was interesting that most of  the B cell 
populations we examined expressed little a3B1 nor did they 
adhere to HFK matrix suggesting that unactivated B cells 
may not be able to interact with epiligrin in epidermal base- 
ment membranes. This could explain the failure of such cells 
to associate with the basement membrane in situ. Failure to 
interact with the basement membrane in the absellce of the 
appropriate activating signals could lead to the "trapping" 
and localization of ct4/31+,  tx5Bl+, a3/31 '°w B cells within 
the fibronectin-rich reticular dermis. Indeed, the in situ im- 
munohistochemistry in this study consistently demonstrated 
a correlation between c~3B1 expression (T cells in reactive 
infiltrates and MF) and a tendency for intraepidermal migra- 
tion.  Malignant  B  cells that were ot3/31  m°w in  situ did not 
show  epidermal  or  superficial  dermal  infiltration.  Since 
epiligrin is confined to the lamina lucida of the basement 
membrane (Carter et al.,  1991), these findings indicate that 
keratinocytes  synthesize  additional  adhesion  molecules, 
such as ICAM-1  (reviewed by Walsh et al.,  1990; Barker et 
al.,  1991;  Barker  and  Nickoloff,  1992),  that  might pro- 
mote the epidermotropism characteristic of cutaneous T cell 
disease. 
Interestingly, in the present experiments mAb P3H9-2 to 
epiligrin-stained endothelial as well as epithelial basement 
membranes. We have now observed epiligrin immunoreac- 
tivity in the endothelium of several tissues including skin, 
lymph node, tonsil, thymus, and lung.  These data suggest 
that a3/31 positive T cells may interact with epiligrin in sub- 
endothelial basement membranes as well as the epidermal 
basement membrane.  Furthermore,  since we have shown 
that endothelial cells express ot3/31 (Languino et al.,  1990), 
these findings suggest that epiligrin may also be involved in 
endothelial cell-basement membrane interactions. In several 
experiments using mAb P1E1 we did not detect epiligrin in 
endothelial basement membranes (Fig.  10 B). This may be 
due to differences in antibody access to the antigen.  How- 
ever, data to be presented elsewhere indicates that the epili- 
grin forms expressed in epidermal and endothelial basement 
membranes are not identical. 
ct3fll interaction with epiligrin has been proposed to be 
a key mechanism used by keratinocytes to adhere to the base- 
ment membrane (Carter et al., 1991). The results of several 
recent studies support this concept. Epiligrin is similar if not 
identical to another recently described epithelial basement 
membrane protein, kalanin (Rousselle et al., 1991; Marinko- 
vich et al.,  1992). mAbs to kalanin induce skin fragments 
to  de-epithelialize  in  culture.  Furthermore,  epiligrin  has 
been shown to be a target in acquired autoimmune and inher- 
ited blistering skin diseases and is identical to the BM600 
antigen which is absent from the skin of patients with lethal 
junctional epidermolysis bullosa (Domioge-Hultsch et al., 
1992). Together, these findings suggest an important role for 
tx3~l and epiligrin in determining the integrity of the skin. 
Our present findings further suggest a primary role for ot3B1 
and epiligrin in determining T lymphocyte activities in the 
basement membrane zone. In addition to epidermal migra- 
tion, vacuolar alteration, satellite cell necrosis of basal kera- 
tinocytes, and blistering are key features of T lymphocyte- 
mediated inflammation. We propose that the interaction of 
activated or memory T cells with epiligrin via ot3B1 contrib- 
utes to their adhesion to the basement membrane in certain 
pathological  cutaneous  T  cell  disorders,  such  as  GVH, 
chronic  eczematous  dermatitis,  and  mycosis  fungoides 
(CTCL). 
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